Jazz Pharmaceuticals (JAZZ)

60.00 +1.51  +2.58%  May 21, 8:00PM
Add to Watchlists Create an Alert

Jazz Pharmaceuticals Cash from Financing TTM:

469.89M for March 31, 2013
View Full Chart

Jazz Pharmaceuticals Cash from Financing TTM Chart

    Jazz Pharmaceuticals Historical Cash from Financing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 469.89M
    Dec. 31, 2012 448.53M
    Sept. 30, 2012 447.74M
    June 30, 2012 419.62M
    March 31, 2012 -48.32M
    Dec. 31, 2011 -33.08M
    Sept. 30, 2011 -35.62M
    June 30, 2011 -6.409M
    March 31, 2011 -26.47M
    Dec. 31, 2010 -27.53M
    Sept. 30, 2010 -21.15M
       
    June 30, 2010 -6.946M
    March 31, 2010 12.52M
    Dec. 31, 2009 12.69M
    Sept. 30, 2009 6.833M
    June 30, 2009 18.20M
    March 31, 2009 21.33M
    Dec. 31, 2008 64.13M
    Sept. 30, 2008 64.98M
    June 30, 2008 42.62M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro

    About Cash From Financing (TTM)

    Definition: Cash from Financing

    Learn More

    Get data for

    JAZZ Cash from Financing TTM Benchmarks

    Companies
    Santarus 5.955M
    Cubist Pharmaceuticals -71.06M
    Catalyst Pharmaceutical Partners 14.58M

    JAZZ Cash from Financing TTM Rankings

    Overall 96th percentile
    297 of 8002
    Sector 97th percentile
    17 of 684 in Healthcare
    Industry 98th percentile
    4 of 248 in Biotechnology

    JAZZ Cash from Financing TTM Range, Past 5 Years

    Minimum -48.32M Mar 2012
    Maximum 469.89M Mar 2013
    Average 91.18M